Publicaciones en colaboración con investigadores/as de Saarland University (14)

2024

  1. Endomyocardial biopsy: safety and prognostic utility in paediatric and adult myocarditis in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Long-Term Registry

    European Heart Journal, Vol. 45, Núm. 28, pp. 2548-2569

  2. Unlocking the effective alliance of β-lapachone and hydroxytyrosol against triple-negative breast cancer cells

    Biomedicine and Pharmacotherapy, Vol. 174

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

2021

  1. Mapping the human genetic architecture of COVID-19

    Nature, Vol. 600, Núm. 7889, pp. 472-477

2020

  1. The a € wait for symptoms' strategy in asymptomatic severe aortic stenosis

    Heart, Vol. 106, Núm. 23, pp. 1792-1797

2017

  1. Does renal function affect the efficacy or safety of a pharmacoinvasive strategy in patients with ST-elevation myocardial infarction? A meta-analysis

    American Heart Journal, Vol. 193, pp. 46-54

2015

  1. Consistency of benefit from an early invasive strategy after fibrinolysis: A patient-level meta-analysis

    Heart, Vol. 101, Núm. 19, pp. 1554-1561

2014

  1. Routine invasive management early after fibrinolysis: Relationship between baseline risk and treatment effects in a pooled patient-level analysis of 7 randomized controlled trials

    American Heart Journal, Vol. 168, Núm. 5, pp. 757-765.e3

2011

  1. Calcium microdomains at the immunological synapse: How ORAI channels, mitochondria and calcium pumps generate local calcium signals for efficient T-cell activation

    EMBO Journal, Vol. 30, Núm. 19, pp. 3895-3912

2010

  1. Early routine percutaneous coronary intervention after fibrinolysis vs. standard therapy in ST-segment elevation myocardial infarction: A meta-analysis

    European Heart Journal, Vol. 31, Núm. 17, pp. 2156-2169

2009

  1. Implications of the European organisation for research and treatment of cancer (EORTC) guidelines on the use of granulocyte colony-stimulating factor (G-CSF) for lymphoma care

    Clinical Drug Investigation, Vol. 29, Núm. 8, pp. 491-513

2005

  1. Reduced-intensity conditioning lowers treatment-related mortality of allogeneic stem cell transplantation for chronic lymphocytic leukemia: A population-matched analysis

    Leukemia, Vol. 19, Núm. 6, pp. 1029-1033

2003

  1. Treatment-related mortality and graft-versus-leukemia activity after allogeneic stem cell transplantation for chronic lymphocytic leukemia using intensity-reduced conditioning

    Leukemia, Vol. 17, Núm. 5, pp. 841-848